Home > Insider Trading > Filing (0001121781-11-000181)

Filing Details

Accession Number:: 0001121781-11-000181
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-06-09 16:07:44
Reporting Period:: 2007-03-01

Filing Date:: 2011-06-09
Accepted Time:: 2011-06-09 15:07:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
924515	Guided Therapeutics Inc	GTHP	Electromedical & Electrotherapeutic Apparatus (3845)	582029543

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1348439	E John Imhoff	5835 Peachtree Corners East Suite D Norcross GA 30092		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2009-05-28	1,872,838	$0.35	2,496,388	No	4	P	Direct
Common Stock	Acquisiton	2009-07-29	581,329	$0.20	3,077,717	No	4	P	Direct
Common Stock	Acquisiton	2010-01-15	20,000	$0.33	3,097,717	No	4	M	Direct
Common Stock	Acquisiton	2010-01-15	20,000	$0.39	3,117,717	No	4	M	Direct
Common Stock	Acquisiton	2010-02-26	997,247	$0.65	4,114,964	No	4	J	Direct
Common Stock	Acquisiton	2010-02-26	767,077	$0.65	4,882,041	No	4	J	Direct
Common Stock	Acquisiton	2010-02-26	1,059,716	$0.65	5,941,757	No	4	J	Direct
Common Stock	Acquisiton	2010-03-30	22,500	$0.00	5,964,257	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	M	Direct
No	4	M	Direct
No	4	J	Direct
No	4	J	Direct
No	4	J	Direct
No	4	A	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	2007 Convertible Notes	Acquisiton	2007-03-01	170,369	$110,740.00	170,369	$0.65
Common Stock	2007 Convertible Notes	Acquisiton	2007-03-01	0	$55,370.00	85,165	$0.65
Common Stock	2007 Convertible Notes	Acquisiton	2007-03-01	0	$249,164.00	383,329	$0.65
Common Stock	2007 Warrants (right to buy)	Acquisiton	2007-03-01	170,369	$0.00	170,369	$0.65
Common Stock	2007 Warrants (right to buy)	Acquisiton	2007-03-01	85,185	$0.00	85,185	$0.65
Common Stock	2007 Warrants (right to buy)	Acquisiton	2007-03-01	383,330	$0.00	383,330	$0.65
Common Stock	Options (right to buy)	Acquisiton	2008-05-14	20,000	$0.00	20,000	$0.33
Common Stock	2008 Convertible Notes	Acquisiton	2008-07-07	0	$150,000.00	230,769	$0.65
Common Stock	2008 Warrants (right to buy)	Acquisiton	2008-07-07	38,462	$0.00	38,462	$0.65
Common Stock	2009 Convertible Notes	Acquisiton	2009-04-13	0	$565,600.00	870,154	$0.65
Common Stock	2009 (warrants (right to buy)	Acquisiton	2009-04-13	2,464,360	$0.00	2,464,360	$0.65
Common Stock	2009 Convertible Notes	Acquisiton	2009-04-15	0	$100,000.00	153,846	$0.65
Common Stock	2009 Warrants (right to buy)	Acquisiton	2009-04-15	157,787	$0.00	157,787	$0.65
Common Stock	Options (right to buy)	Acquisiton	2009-05-22	20,000	$0.00	20,000	$0.39
Common Stock	Options (right to buy)	Disposition	2010-01-15	20,000	$0.33	20,000	$0.33
Common Stock	Options (right to buy)	Disposition	2010-01-15	20,000	$0.39	20,000	$0.39
Common Stock	Series A Convertible Preferred Stock	Disposition	2010-02-26	33,330	$15.00	997,247	$0.65
Common Stock	2010 Warrants (right to buy)	Acquisiton	2010-02-26	384,663	$0.00	384,663	$0.65
Common Stock	2007 Convertible Notes	Disposition	2010-02-26	0	$359,904.00	767,077	$0.65
Common Stock	2009 Convertible Notes	Disposition	2010-02-26	0	$665,800.00	1,059,716	$0.65
Common Stock	Options (right to buy)	Acquisiton	2010-03-30	22,500	$0.00	22,500	$0.98

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	P	Direct
0			No	4	P	Indirect
0			No	4	P	Indirect
170,369	2007-03-01	2013-03-01	No	4	P	Direct
85,185	2007-03-01	2013-03-01	No	4	P	Indirect
383,330	2007-03-01	2013-03-01	No	4	P	Indirect
20,000		2018-05-18	No	4	A	Direct
0			No	4	P	Indirect
38,462	2008-07-07	2013-03-01	No	4	P	Indirect
0			No	4	P	Direct
2,464,360	2009-04-13	2013-03-01	No	4	P	Direct
0			No	4	P	Direct
2,622,147	2009-04-15	2013-03-01	No	4	P	Direct
20,000		2019-05-22	No	4	A	Direct
0		2018-05-14	No	4	M	Direct
0		2019-05-22	No	4	M	Direct
0			No	4	J	Direct
384,663	2010-02-26	2013-03-01	No	4	J	Direct
0			No	4	J	Direct
0			No	4	J	Direct
22,500		2020-03-30	No	4	A	Direct

Footnotes

On February 26, 2010, the issuer reclassified its Series A Convertible Preferred Stock into Common Stock and Warrants to purchase Common Stock, at a rate of approximately 23.077 shares of Common Stock and Warrants to purchase approximately 11.54 shares of Common Stock for each shares of Series A Convertible Preferred Stock.
On February 26, 2010, upon reclassification of the issuer's Series A Convertible Preferred Stock, all of the issuer's outstanding convertible notes were automatically converted into shares of Common Stock with the number of shares calculated by dividing the aggregate principal amount outstanding, plus accrued interest, by $0.65 per share. The expiration date of all warrants issued in conjunction with the convertible notes was extended to March 1, 2013 and, to the extent the exercise price was greater than $0.65, the exercise price was lowered to that amount.
Pursuant to a domestic relations order dated 4/2/2009, the reporting person no longer reports as beneficially owned these securities, which are owned by his ex-wife.
These options were granted under the Guided Therapeutics, Inc. 1995 Stock Plan, as amended, and were fully vested as of 12/31/2008.
The reporting person's son no longer resides in the reporting person's household, and thus the reporting person no longer has a beneficial interest in these securities.
These options were granted under the Guided Therapeutics, Inc. 1995 Stock Plan, as ammended, and were fully vested as of 12/31/2009.
Includes 227,921 shares of Common Stock issued in lieu of accrued but unpaid dividends on the Series A Convertible Preferred Stock.
Includes securities previously owned JTROS with the reporting persons' ex-wife. Pursuant to a domestic relations order dated 4/2/2009, subsequent to that date, the reporting person reports such securities as directly owned.
Includes approximately $138,695 in accrued but unpaid interest.
Includes approximately $23,215.45 in accrued but unpaid interest.
These options were granted under the Guided Therapeutics, Inc. 1995 Stock Plan, as amended, and were fully vested as of 12/31/2010.